OraSure Technologies, Inc.

359 articles with OraSure Technologies, Inc.

• OraSure Technologies to Present at Upcoming Investor Conferences - Nov 19, 2021

  11/19/2021

  OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, announced that Dr. Stephen S. Tang, President and CEO, will participate in a virtual fireside chat at the Stephens Annual Investment Conference on November 29, 2021 at 12:00 pm ET.

• OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

  11/9/2021

  OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that after almost 21 years of service to the Company, Jack E. Jerrett is retiring as the Company’s Senior Vice President, General Counsel, Chief Compliance Officer and Secretary, effective as of December 31, 2021.

• OraSure Technologies Appoints Two New Members to the Board of Directors

  11/8/2021

  OraSure Technologies, Inc. announced today the appointment Nancy J. Gagliano, M.D. and Anne C. Whitaker to the Company’s Board of Directors, effective November 8, 2021. 

• OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

  11/3/2021

  OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended September 30, 2021.

• U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

  11/2/2021

  OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that the EUA for its InteliSwab™ COVID-19 rapid tests has been amended by the U.S. Food and Drug Administration to only require one test for individuals with symptoms of COVID-19.

• OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET

  10/27/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 3, 2021.

• OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver

  9/23/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that the Biomedical Advanced Research Development Authority (BARDA), will provide up to $13.6 million in funding for the Company to obtain 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for OraSure’s InteliSwab™ COVID-19 rapid test from the Food and Drug Administration (FDA).

• OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

  9/20/2021

  OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that the Defense Logistics Agency has awarded the Company a procurement contract for its InteliSwab™ COVID-19 Rapid Test for over-the-counter use, which the Defense Logistics Agency estimated to have a value of $205 million.

• OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

  9/2/2021

  OraSure Technologies, Inc., a global leader in point-of-care testing and sample collection technologies, announced that Chief Financial Officer Roberto Cuca has resigned from the Company effective September 17, 2021.

• OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

  8/3/2021

  OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended June 30, 2021.

• OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

  7/27/2021

  OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET on Tuesday, August 3, 2021.

• OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

  6/17/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Raymond James 2021 Human Health Innovation Conference

• OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

  6/14/2021

  OraSure Technologies, Inc. announced that it is collaborating with the Will Rodgers Liver Health Foundation to increase awareness around the role Hepatitis C plays in chronic liver disease and promoting testing services for HCV within the United States.

• OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

  6/7/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 rapid antigen tests, which the Company is branding as InteliSwab™. These tests detect active COVID-19 infection. The FDA has authorized the InteliSwab ™ COVID-19 Rapid Test for Over-the-Counter (OTC) use without a prescription. FDA has also authorized the InteliSwa

• OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference - May 28, 2021

  5/28/2021

  OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference.

• OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

  5/18/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT.

• OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

  5/17/2021

  OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications.

• OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

  5/12/2021

  OraSure Technologies, Inc., announced that its 2021 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern on Tuesday, May 18, 2021.

• OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

  5/5/2021

  First Quarter 2021 Net Revenues of $59 Million Increased 85% Over 2020, Driven by $27 Million in Sales of Sample Collection Devices for COVID-19 Molecular Testing

• OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

  4/30/2021

  OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 5, 2021.